Home » Newsletters » BioWorld Asia

BioWorld Asia

Oct. 27, 1999

View Archived Issues

Commission Calls For Stricter EU Restrictions On GM Foods

Genset Signs New Deal With GI To Include Gene Library Access

Fouron Resigns From IDM

Thallia Forced To Close Shop After Failing To Get Financing

Swiss Researchers Elucidate Mediation Of GABA Subtypes

Canadian Group Uses Toxins To Remove Cancer From Cells

Hepavec Gets Option On Ovine Adenovirus For Gene Therapy

Wellcome Trust Invests #10M To Help Identify Cancer Genes

BIA Members Agree To Code Governing Communications

ExonHit Launches Product That Assesses Toxicology

Irish Minister Reveals U.S. Lobbied On Behalf Of GMOs

D-Pharm Named Top Startup Company In Israeli Healthcare

Prolifix Enters Collaboration On Factor With Lilly, Chugai

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 23, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.